No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Pemafibrate does not reduce cardiovascular risk in patients with type 2 diabetes and elevated triglycerides

byKeerthana Pasumarthi

November 9, 2022

in StudyGraphics

Reading Time: 1 min read

Contemporary pattern of treatment time and in-hospital mortality among US patients with ST-segment elevation myocardial infarction between 2018-2021

RelatedReports

Exercise improves aromatase inhibitor-induced arthralgia in breast cancer survivors

Chronic Disease

Resistance training is associated with lower risk of type 2 diabetes

July 2, 2026

Sleep duration inversely related to childhood type 2 diabetes risk makers

Chronic Disease

TikTok’s cortisol face trend meets endocrine reality

June 26, 2026

Computed tomography improves diagnostic certainty in the emergency department

Cardiology

Two scores for risk stratification of adults presenting with syncope may be effective at identifying those with low risk

May 29, 2026

$Antiarrhythmic drugs have no survival benefit in shock-refractory out-of-hospital cardiac arrest$

Cardiology

Resuscitative endovascular balloon occlusion of the aorta may not improve outcomes in adults with non-traumatic out-of-hospital cardiac arrest

May 14, 2026

#VisualAbstract: Timing of daily antihypertensives does not change cardiovascular outcomes

Increased frailty associated with childhood cancer survivorship

United States-based chemotherapy regimen for Ewing sarcoma is more effective and safer than the standard European regimen

Improved glycemic control in type 1 diabetics on very low-carbohydrate diets

Wellness Check: Nutrition

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports